![CABOMETYX Differentiated Thyroid Cancer black female patient portrayal](/sites/default/files/styles/webp/public/2023-11/dtc-hero.png.webp?itok=IoEn7lVZ)
Patient portrayal
Differentiated thyroid cancer*
A LOOK AT THE TREATMENT JOURNEY
*papillary or follicular thyroid cancer (2 types of differentiated thyroid cancer) that has progressed on a VEGFR-targeted/tyrosine kinase inhibitor medicine and radioactive iodine is not an option.
If you are being treated for papillary or follicular thyroid cancer — 2 types of differentiated thyroid cancer — you may be wondering “what’s next”?
Everyone's journey is unique. Learning as much as you can about your condition will help you make decisions about your future.
Understanding next steps
It’s Your Journey
The information here may help you learn about your options, whether you are taking your initial — first-line — VEGFR-targeted/tyrosine kinase inhibitor (TKI) medicine or considering your next — second-line — TKI medicine.
Knowing your options will help you have an informed conversation with your doctor, who is your best resource for discussing your treatment or condition. Together, you will be able to choose what medicine is right for your situation.
How you may move forward depends on where you are in your journey.
Click on the tab below that best describes your situation.
Sometimes a first-line TKI medicine isn't appropriate anymore. Maybe your condition is progressing or you need another treatment option. If you can’t receive radioactive iodine (RAI), your doctor may discuss using a different TKI medicine. You do have choices. Learn about your options so you can actively participate in your care.
Understanding your options may help you get the treatment that's right for your situation. You can use what you learned from your treatment experience to advocate for yourself by asking your doctor specific questions and expressing your preferences and concerns.
Understand Your Options if Your Condition Progresses
Hear from Cory Lee, an actual patient, why it's important to learn about your treatment options.
If your condition or the condition of someone you care for is progressing on a first-line VEGFR-targeted/TKI medicine and RAI isn't an option, CABOMETYX may be right for you. More about CABOMETYX
![CABOMETYX Doctor Discussion Guide](/sites/default/files/2020-04/600X900.png)
Talking to Your Doctor
Get a Doctor Discussion Guide to help make the most of your medical appointments. You can use the guide to organize what you want to talk about regarding your treatment and goals, including:
- What are my treatment options?
- What is CABOMETYX?
- How is CABOMETYX thought to work?
This is a good time to learn more about your condition and treatments. Learning as much as you can allows you to actively participate in your care and may help you feel more in control.
Understanding your options will help you be prepared if your condition progresses or if you need to change your medicine (take a second-line TKI). You will be able to advocate for yourself by asking your doctor specific questions and expressing your preferences and concerns. Though you may not need to change your medicine now, you can be ready if you have to in the future.
The Treatment Journey: Stages and Terms You Should Know
Follow the journey of Cory Lee, an actual patient, and learn about different treatments, terms, and important tips.
![CABOMETYX Doctor Discussion Guide](/sites/default/files/2020-04/600X900.png)
Learn About CABOMETYX, a Second-Line TKI Medicine
Find out why CABOMETYX may be right for people whose condition progresses on a first-line VEGFR-targeted/TKI medicine and they can't have radioactive iodine (RAI). This handbook will help you understand CABOMETYX, including:
- How it is thought to work
- Results of the clinical trials
- Available treatment education and financial support information
If you or someone you are caring for is taking a first-line TKI medicine, you may have to change treatments. Ask your doctor at what point CABOMETYX may be right for you. Learn about CABOMETYX
Learn about CABOMETYX
What is CABOMETYX?
Though there are other TKIs, CABOMETYX is the only FDA-approved second-line TKI medicine for people with papillary or follicular thyroid cancer (2 types of differentiated thyroid cancer) who have progressed after treatment with a VEGFR-targeted/TKI medicine and can't receive RAI.
![Patient Cory Lee](/sites/default/files/2023-12/lee-patient-m.png)
“You’ve got to know your options. So it's important to do your own research to find out what options you do have.”
Cory Lee, an actual patient
Cory Lee's Story
Air Force veteran Cory Lee, an actual patient, shares his story. Track his journey from diagnosis to how he worked through the tough times with his family and support network.
SUPPORT AND ADVOCACY GROUPS
Organizations you may find helpful
American Thyroid Association
Contact via website only
www.thyroid.org/thyroid-cancer
ThyCa: Thyroid Cancer Survivors’ Association
Contact via website only
www.thyca.org
Light of Life Foundation
Contact via website only
lightoflifefoundation.org
Cancer Support Community
Contact via website only
www.mylifeline.org
National Organization for Rare Disorders
Contact via website only
www.rarediseases.org/thyroid-cancer
CancerCare®
American Cancer Society®
The National Cancer Institute
These are third-party organizations and websites that are not owned or controlled by Exelixis, Inc. and their inclusion does not constitute endorsement of CABOMETYX. Exelixis, Inc. makes no representation regarding the content, accuracy or completeness of the information provided by these organizations and on these third-party websites. Use and access to the information on these third-party websites are subject to the terms, limitations and conditions set by those websites.